Through the analysis of the GRASSO prostate cancer database[23], we found that the expression of RACGAP1 was significantly increased in patients with PTEN, RB1, and E2F1 gene mutations, suggesting that E2F1 was related to RACGAP1 (Supplementary Fig. 4A-C). Here, RACGAP1 is linked to prostate carcinoma.